After Hours Gainer
NITO N2off5.50+0.08+1.5%
After Hours:10.12+4.62 (+84.0%)
N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
Globe NewswireThu, 25-Sep 4:01 PM
